Navigation Links
Pioneer(R) Surgical Technology, Inc. and Bonovo(R) Orthopedics, Inc. Establish Foothold in Fastest Growing Spine Market in the World
Date:11/17/2009

MARQUETTE, Mich., Nov. 17 /PRNewswire/ -- Bonovo Orthopedics, Inc., a leading Chinese manufacturer and distributor of orthopedic products, has received government approval to market Pioneer's full portfolio of spinal fusion products.

Bonovo is a sponsor of the Chinese Orthopaedic Association annual meeting - the largest and most international professional spine meeting in that country - and is planning a comprehensive rollout of Pioneer's Quantum® spinal rodding, disc spacer, and cervical plating systems.

Pioneer's Chief Marketing Officer and General Manager of Spinal Operations, Thomas McLeer says, "While it has taken a long time to get these products approved, there is an interesting advantage to have all of these products gaining approval at approximately the same time in that we are hitting the market in 2010 with a complete Pioneer 'fusion system'...not just individual products."

"With Pioneer's leading-edge technology and Bonovo's customer service and support, we are confident that Pioneer Surgical will become the preferred brand by leading orthopedic surgeons throughout China. We are excited to get started," stated Bonovo's CEO, Peter Slate.

Pioneer and Bonovo, in 2008, signed a comprehensive agreement for the distribution and sale of Pioneer products in China with Bonovo serving as Pioneer's exclusive distributor of its products for the Chinese spine market.

About Pioneer Surgical Technology, Inc.

Pioneer Surgical Technology, Inc. is a dynamic medical device firm headquartered in Marquette, Michigan. They have advanced Biologic research, development, and manufacturing facilities in Greenville, North Carolina and Woburn, Massachusetts. Pioneer has a full line of motion preservation devices available commercially in Europe or under clinical evaluation in the U.S. In addition, they offer diverse spinal fusion systems. Pioneer's signature articulating P3® Technology - Pioneer PEEK-on- PEEK - is vital to their nucleus replacement system, NuBac®, which is currently in U.S. clinical trials. Pioneer's focus on innovation has resulted in over 120 U.S. and foreign patents, with numerous patents pending. Pioneer is dedicated to developing products that positively impact the lives of patients, employees, and business associates, are easier and faster for surgeons, and are cost effective for the healthcare system. For more information on Pioneer and its products visit www.pioneersurgical.com.

About Bonovo Orthopedics, Inc.

Bonovo Orthopedics, Inc. is a premier developer, manufacturer, and distributor of orthopedic implants and other products to the orthopedic and neurosurgical markets. Bonovo has been a leader in the Chinese orthopedic industry for over 15 years. Bonovo distributes its own products and serves as a distribution partner for other leading international companies. The Bonovo team is committed to driving new standards of orthopedic care throughout China by bringing the best products to market - products that combine strong market demand with great social benefit. For more information on Bonovo and its products visit www.bonovo-ortho.com.

SOURCE Pioneer Surgical Technology, Inc.


'/>"/>
SOURCE Pioneer Surgical Technology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
2. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
3. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
4. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
5. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
6. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
7. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
8. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
9. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
10. Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination
11. New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... , May 27, 2016 LabStyle ... Dario™ Diabetes Management Tool, today announced that the Company,s Chief ... Marcum MicroCap Conference being held June 1-2 in ... being held June 7-9 in Los Angeles, CA. ... discuss recent corporate and operational milestones, including the U.S. FDA ...
(Date:5/27/2016)... 2016 Hutchison China MediTech ... on the highly lucrative global oncology and immunology ... potential first-in-class or best-in-class tyrosine kinase inhibitor (TKI) ... strategic partners. HCM,s profitable Chinese healthcare business continues ... expect progress of the mid-to-late-stage pipeline during 2016-17 ...
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... and Orphan Diseases, today announced that President & CEO Gerald ... SeeThru Equity MicroCap Conference   Where: ... , NY When: Tuesday, May 31 st , ... Where: Grand Hyatt Hotel, 109 East 42 nd St, ...
Breaking Medicine Technology:
(Date:5/31/2016)... CA (PRWEB) , ... May 31, 2016 , ... WaterField ... for digital-minded professionals, announces the waxed-canvas and leather Duo Dopp Kit , the ... waxed canvas or ballistic nylon, the Duo is smartly designed for Dad’s ...
(Date:5/31/2016)... ... ... Interest is on the rise for using the CRISPR-Cas9 system for functional ... hit validation. A key reason may be that high-throughput synthesis—combined with a proprietary algorithm ... collections in arrayed formats. , Arrayed crRNA screens have the advantage ...
(Date:5/31/2016)... ... May 31, 2016 , ... MinerEye ... Vendors in Security Infrastructure Protection report by Gartner1 Inc. , Each year, Gartner ... research reports evaluating these innovative vendors and their products and services. , According ...
(Date:5/31/2016)... , ... May 31, 2016 , ... ... media enterprise focused on patients with cancer, has added Cancer and Careers ... website visitors with more timely content on continuing successful careers while fighting cancer. ...
(Date:5/30/2016)... Salt Lake City, Utah (PRWEB) , ... May ... ... health insurance reimbursement for small businesses, announced today the publication of an original ... helps business owners and health insurance professionals understand how Zane Benefits complies with ...
Breaking Medicine News(10 mins):